Print version of this report
TGA Action ID RC-2026-RN-00911-1
Type of Product Medical Device
Product Name/Description Salix (AU)

Product Version: 1.8.0

Manufacturing Date: 12-March-2025
ARTG Number 516525
Unique Device Identifier (UDI) 09369999329914
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action A defect was identified following the release of Salix Coronary Plaque (SCP) v1.2 in Australia, where clinicians observed that MESA percentiles were no longer being automatically generated for some patients where ethnicity information was not available.

Investigation determined that SCP v1.2 had corrected the handling of missing ethnicity values by removing the historical default ethnicity assignment. As part of the investigation, other commercially distributed software variants were reviewed, and it was identified that Salix (AU), prior to SCP v1.2, contained a defect whereby the MESA percentile calculation defaulted ethnicity to Caucasian when no ethnicity was specified. This default value was applied in the background and was not visible to the user.

An incorrect MESA percentile was presented to clinicians due to this software defect. This may have resulted in the patient's coronary calcium burden being represented inaccurately relative to the reference population.

No adverse events, serious injuries, or deaths associated with this problem have been reported.
Instructions for Customers/Users Customers are to:
- Review historical studies processed using the affected Salix (AU) version prior to SCP v1.2 as they may have contained an incorrect MESA percentile when ethnicity was not specified.

The defect has been corrected in SCP v1.2, which removed the unintended ethnicity default within the MESA percentile calculation workflow.
Action Commencement Date 9/11/2026
Responsible Entity Artrya Ltd
Contact Information 0405 653 605 - Gabriela Quijada